97083 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors Serine protease (E.C. 3.4.21) inhibitors
Sub-classes:FUSION PROTEIN INHIBITORS OF KLK5
#2THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
#3CHIMERIC ANTIGEN RECEPTOR (CAR) MODULATION
#4Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#5PEPTIDE LIBRARY AND USE THEREOF
#6SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#7SMALL MOLECULE-REGULATED GENE EXPRESSION SYSTEM
#8KLK5 INHIBITORY PEPTIDE
#9PROKARYOTIC AND EUKARYOTIC CELLS WITH BIOSYNTHESIZED SULFOTYROSINE FOR GENETIC INCORPORATION
#10CYSTINE KNOT SCAFFOLD PLATFORM
#11COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES
#12Application of MmPI in Preparation of Trypsin Inhibitors
#13Application of MmBBK2 in Preparation of Trypsin and Chymotrypsin Inhibitors
#14NOVEL IL-15 PRODRUGS AND METHODS OF USE THEREOF
#15METHODS FOR PURIFYING INTER-ALPHA INHIBITOR PROTEINS
#16IMPROVED THROMBIN INHIBITORS FOR TREATMENT OF THROMBOEMBOLIC CONDITIONS
#17COILED COIL IMMUNOGLOBULIN FUSION PROTEINS AND COMPOSITIONS THEREOF
#18Therapeutic variant alpha-2-macroglobulin compositions
#19NEUTROPHIL ELASTASE BINDING PEPTIDES AND COMPOSITIONS THEREOF
#20Methods for treating pulmonary disease using inter-alpha inhibitor proteins
#21CYSTINE KNOT SCAFFOLD PLATFORM
#22Recombinant protein and fragments thereof, method for producing said recombinant protein, synthetic gene and use of sculptin or recombinant protein for preparing a medicament or pharmaceutical composition for the prophylaxis and/or treatment of thromboembolic diseases or as a direct and specific inhibitor of thrombin
#23SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#24KLK5 inhibitory peptide
#25Chimeric antigen receptor (CAR) modulation
#26NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS
#27METHOD OF TREATING ATHEROSCLEROSIS
#28IMMUNOMODULATORY CELLS AND USES THEREOF
#29Method for producing washing enzyme having protease resistance
#30Chymotrypsin Inhibitor Variants And The Use Thereof
#31KLK5 inhibitory peptide
#32MODIFIED SERINE PROTEINASE INHIBITORS AND APPLICATIONS THEREOF
#33Self-Assembling Multi-Domain Peptide Based Hydrogels
#34Therapeutic variant alpha-2-macroglobulin compositions
#35Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same
#36Serpin fusion polypeptides and methods of use thereof
#37Serpin fusion polypeptides and methods of use thereof
#38IL-15 prodrugs and methods of use thereof
#39Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#40CYSTINE KNOT SCAFFOLD PLATFORM
#41Chimeric antigen receptor (CAR) modulation
#42Coiled coil immunoglobulin fusion proteins and compositions thereof
#43MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#44Antimicrobial peptide and its use thereof
#45Conjugated knottin mini-proteins containing non-natural amino acids
#46Cystine knot scaffold platform
#47Peptide library and use thereof
#48Therapeutic variant alpha-2-macroglobulin compositions
#49Cystine knot scaffold platform
#50Therapy using a factor XII inhibitor in a neurotraumatic disorder
#51Serpin fusion polypeptides and methods of use thereof
#52Cystine knot scaffold platform
#53SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#54Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#55Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression
#56Thrombin inhibitors for treatment of stroke and related coagulative disorders
#57NOVEL MEANS TO DECREASE THE NEGATIVE EFFECTS OF SMOKING
#58THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS
#59Method of treating atherosclerosis
#60PEPTIDES AND METHODS OF USE THEREOF
#61METHODS FOR TREATING PULMONARY DISEASE USING INTER-ALPHA INHIBITOR PROTEINS
#62MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#63Peptides having tetrahedral mimicking groups as inhibitors of rhomboid proteases
#64Fusion proteins for treating inflammatory diseases
#65Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes
#66Thrombin inhibitors
#67TREATMENT OF DISEASE WITH LACTIC ACID BACTERIA HAVING STABLY INTEGRATED TRAPPIN-2
#68Cystine knot scaffold platform
#69Serpin fusion polypeptides and methods of use thereof
#70MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
#71Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs
#72Compositions and methods for diagnosis and treatment of cancer
#73Compounds for the treatment of cancer
#74Therapeutic variant alpha-2-macroglobulin compositions
#75Conjugated knottin mini-proteins containing non-natural amino acids
#76ECOTIN VARIANTS
#77Methods of generating bioactive peptide-bearing antibodies and compositions comprising the same
#78TAT-CrmA anti-apoptotic fusion proteins
#79Cystine knot scaffold platform
#80THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER
#81Pharmaceutical composition with improved stability containing factor VII fusion protein
#82High-selectivity contact activation inhibitor based on infestin-4
#83Beta-hairpin peptidomimetics as selective elastase inhibitors
#84POTENT INHIBITORS OF HUMAN MATRIPTASE DERIVED FROM MCOTI-II VARIANTS
#85NOVEL MEANS TO DECREASE THE NEGATIVE EFFECTS OF SMOKING
#86Coiled coil immunoglobulin fusion proteins and compositions thereof
#87Preparation and composition of inter-alpha inhibitor proteins from blood
#88Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
#89Bovine fusion antibodies
#90Nucleotide sequence and a process thereof
#91Conjugated knottin mini-proteins containing non-natural amino acids
#92Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
#93Peptide library and use thereof
#94Serpin fusion polypeptides and methods of use thereof
#95WAP domain fusion polypeptides and methods of use thereof
#96Serpin fusion polypeptides and methods of use thereof
#97Method for effective management of helicoverpa armigera
#98Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
#99CELL THERAPY TECHNOLOGY TO DELIVER RADIO-PROTECTIVE PEPTIDES
#100Manufacture of inter-alpha-inhibitor (IaIp) from plasma
#101Factor XII inhibitors for the treatment of neurological inflammatory disorders
#102Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#103Identification and molecular characterisation of proteins, expressed in the salivary glands
#104Maspin-based treatment of cancer
#105Multi-Gene Expression Vehicle
#106Multi-leu peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#107Single chain antibodies that specifically bind to the activated state of the platelet integrin receptor GP IIb/IIIa
#108Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#109Bovine fusion antibodies
#110Macrocyclic proline derived HCV serine protease inhibitors
#111Novel Proteinase Inhibitor Promotes Resistance to Insects
#112Locally-active anticoagulants and anti-inflammatory agents
#113Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
#114Serpin fusion polypeptides and methods of purification thereof
#115Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#116Modified variant Bowman Birk protease inhibitors
#117Thrombin inhibitor
#118Identification and molecular characterisation of proteins, expressed in the salivary glands
#119PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES
#120Method for Recovering Kunitz-Trypsin Inhibitor Proteins from a Soy Processing Stream
#121Purified Bowman-Birk Protease Inhibitor Proteins Isolated from a Soy Processing Sttream
#122WAP domain fusion polypeptides and methods of use thereof
#123Serpin fusion polypeptides and methods of use thereof
#124Method for removing a lytic enzyme from a heterogeneous mixture
#125SOY WHEY PROTEIN COMPOSITIONS AND METHODS FOR RECOVERING SAME
#126Targeting the neuromuscular junction for treatment
#127Methods and compositions for inhibiting angiogenesis
#128Method for Recovering Bowman-Birk Inhibitor Proteins from a Soy Processing Stream
#129Maspin-based peptides and methods of use thereof
#130Purified Kunitz Trypsin Inhibitor Proteins Isolated from a Soy Processing Stream
#131Antithrombotic compounds
#132RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS)
#133Variants of pigment epithelium derived factor and uses thereof
#134METHOD OF MODIFYING SERINE PROTEASE INHIBITORS
#135Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#136Macrocyclic proline derived HCV serine protease inhibitors
#137Genetically modified TFPI and method of treating coagulation using the same
#138Manufacture of inter-alpha-inhibitor (IaIp) from plasma
#139Anti-apoptotic fusion proteins for reducing myocardial infarction size
#140PROTEASES TARGETING AGENTS
#141Modified variant Bowman Birk Protease Inhibitors
#142CYSTINE KNOT MOLECULES
#143Novel Regulators of the Innate Immune System
#144Peptides and Supported Peptides for Treating Skin Diseases
#145Expression of Streptomyces Subtilisin Inhibitor (SSI) Proteins In Bacillus and Streptomyces sp.
#146Preparation and composition of inter-alpha proteins from blood
#147Information processing apparatus and boot completion notification program
#148Multi-LEU peptides and analogues thereof as selective PACE4 inhibitors and effective antiproliferative agents
#149MACROCYCLIC COMPOUNDS, PROTEASE INHIBITION, AND METHODS OF TREATMENT
#150ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#151Use of cyclic depsipeptides to inhibit kallikrein 7
#152POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE POLYPEPTIDE
#153ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#154Chimeric antigen-specific T cell-activating polypeptides
#155ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#156PROTEASE INHIBITOR
#157COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#158Methods and compositions for inhibiting angiogenesis
#159Cystine knot molecules
#160ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#161Anti-angiogenic nanoparticle compositions
#162Nematode-extracted serine protease inhibitors and anticoagulant proteins
#163THE USE OF A VEGF BINDING PEPTIDE TO RETARD HAIR GROWTH
#164Modified variant Bowman Birk protease inhibitors
#165Nucleic acids encoding genetically modified tissue factor pathway inhibitor (TFPI) and method of making the same
#166COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2
#167Anti-inflammatory and anti-allergic cyclic peptides
#168COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#169Modified variant bowman birk protease inhibitors
#170Rearranged squamous cell carcinoma antigen genes
#171Diagnosis of carcinomas
#172ANTICOAGULATION AGENT AND USES THEREOF
#173Variants of pigment epithelium derived factor and uses thereof
#174Proteins Involved in After-Cooking Darkening in Potatoes
#175Directed evolution of novel binding proteins
#176Heteroaryl-containing tripeptide HCV serine protease inhibitors
#177Anti-cancer agent comprising protein C inhibitor
#178Trappin-2 (elafin) inhibits HIV
#179Anticoagulation Agent and Uses Thereof
#180Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF)
#181Compositions comprising bowman-birk protease inhibitors and variants thereof
#182Diagnosis of carcinomas
#183ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#184Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments
#185Method of protein production in yeast
#186ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#187MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS
#188Variants of pigment epithelium derived factor and uses thereof
#189FGF-5 Supported and Binding Peptides
#190Expression in filamentous fungi of protease inhibitors and variants thereof
#191Modified peptides and their uses
#192Process for manufacture of nematode-extracted anticoagulant protein (NAP)
#193Identification and molecular characterisation of proteins, expressed in the salivary glands
#194Pharmaceutical Compositions Preparation of Peptides, Secreted by the Snake Venom Glands, Particularly of Bothrops Jararaca, Vasopeptidases Inhibitors, Evasins, Their Analogues, Derivatives and Products Associated, Thereof, for Development of Applications and Use in Chronic-Degenerative Diseases
#195Anti-angiogenic methods and compositions
#196ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#197Management of devices connected to infiniband ports
#198Nucleic acids encoding monomers of a type II serine proteinase inhibitor
#199Expression in filamentous fungi of protease inhibitors and variants thereof
#200Anti-angiogenic methods and compositions
#201Tgfbeta Supported and Binding Peptides
#202Anti-angiogenic methods and compositions
#203Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
#204PROTEASE INHIBITORS AND METHOD OF SCREENING THEREOF
#205Isolated nucleic acid sequence conferring stress tolerance/susceptibility in rice
#206Multifunctional protease inhibitors and their use in treatment of disease
#207ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#208ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#209Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
#210Retinal pigmented epithelium derived neurotrophic factor
#211MULTI-GENE EXPRESSION VEHICLE
#212Rearranged squamous cell carcinoma antigen genes II
#213MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS
#214Proteinase inhibitor, precursor thereof and genetic sequences encoding same
#215Thrombin-inhibiting peptides
#216Modified pro-α peptides and their uses
#217Method for site-specific protein modifications
#218Anti-angiogenic compositions and methods of use
#219Anti-angiogenic compositions and methods of use
#220Method for separating and concentrating biological materials using continuous-flow ultracentrifugation
#221Nematode-extracted serine protease inhibitors and anticoagulant proteins
#222Anti-angiogenic compositions and methods of use
#223Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP)
#224Anti-angiogenic methods and compositions
#225Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf)
#226Anti-angiogenic compositions and methods of use
#227Novel human secreted proteins and polynucleotides encoding the same
#228Anti-angiogenic compositions and methods of use
#229Peptidic thrombin inhibitors
#230Polypeptides and polypeptide analogues
#231Alteration of amino acid compositions in seeds
#232Anti-angiogenic compositions and methods of use
#233Anti-angiogenic compositions and methods of use
#234Anti-angiogenic compositions and methods of use
#235Anti-angiogenic compositions and methods of use
#236Cyclic molecular framework and derivatives thereof
#237Anti-angiogenic compositions and methods of use
#238Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene
#239Isolated monomers of a type II serine proteinase inhibitor
#240FGF-5 supported and binding peptides
#241Prostasin substrates and inhibitors
#242Enzyme/tag binding and detection system
#243Anti-angiogenic compositions and methods of use
#244Peptides and supported peptides for treating skin diseases
#245Bacterial expression of bowman-birk protease inhibitors and variants thereof
#246Nematode-extracted serine protease inhibitors and anticoagulant proteins
#247Methods for protein production
#248Reagents and methods for treating epilepsy, traumatic injury and other pathologies of the brain
#249Expression in filamentous fungi of protease inhibitors and variants thereof
#250Pigment epithelium derived factor from human plasma and methods of use thereof
#251Anti-angiogenic compositions and methods of use
#252Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
#253Viral vector encoding pigment epithelium-derived factor
#254Novel human protease inhibitor-like proteins and polynucleotides encoding the same
#255Methods of protein production in yeast
#256Compositions of sunflower trypsin inhibitors
#257Novel human protease inhibitor proteins and polynucleotides encoding the same
#258Protein induced by homogeneous blood transfusion and DNA encoding the same
#259Novel serine protease inhibitory protein mt0039
#260Anti-angiogenic compositions and methods of use
#261Method for controlling the yield and purity of proteinase inhibitor II during extraction
#262Hypoallergenic transgenic soybeans
#263Expression cassettes for producing plants with increased levels of essential amino acids
#264Immunization and/or treatment of parasites and infectious agents by live bacteria
#265Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria